Angela Shysh

Dr. Angela Shysh

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ZSZoya Serebrovska
Zoya Serebrovska
TSTetiana Serebrovska
Tetiana Serebrovska
VKViktor kholin
Viktor kholin
LTLesya V. Tumanovska
Lesya V. Tumanovska
ASAngela Shysh
Angela Shysh
VDVictor E. Dosenko
Victor E. Dosenko
Alzheimer’s disease (AD) affects not only the central nervous system, but also peripheral blood cells including neutrophils and platelets, which actively participate in pathogenesis of AD through a vicious cycle between platelets aggregation and production of excessive amyloid beta (Aβ). Platelets adhesion on amyloid plaques also increases the risk of cerebral microcirculation disorders. Moreover, activated platelets release soluble adhesion molecules that cause migration, adhesion/activation of neutrophils and formation of neutrophil extracellular traps (NETs), which may damage blood brain barrier and destroy brain parenchyma. The present study examined the effects of intermittent hypoxic-hyperoxic training (IHHT) on elderly patients with mild cognitive impairment (MCI), a precursor of AD. Twenty-one participants (age 51–74 years) were divided into three groups: Healthy Control (n = 7), MCI+Sham (n = 6), and MCI+IHHT (n = 8). IHHT was carried out five times per week for three weeks (total 15 sessions). Each IHHT session consisted of four cycles of 5-min hypoxia (12% FIO2) and 3-min hyperoxia (33% FIO2). Cognitive parameters, Aβ and amyloid precursor protein (APP) expression, microRNA 29, and long non-coding RNA in isolated platelets as well as NETs in peripheral blood were investigated. We found an initial decline in cognitive function indices in both MCI+Sham and MCI+IHHT groups and significant correlations between cognitive test scores and the levels of circulating biomarkers of AD. Whereas sham training led to no change in these parameters, IHHT resulted in the improvement in cognitive test scores, along with significant increase in APP ratio and decrease in Aβ expression and NETs formation one day after the end of three-week IHHT. Such effects on Aβ expression and NETs formation remained more pronounced one month after IHHT. In conclusion, our results from this pilot study suggested a potential utility of IHHT as a new non-pharmacological therapy to improve cognitive function in pre-AD patients and slow down the development of AD.

1 August 2017 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
ZSZoya Serebrovska
Zoya Serebrovska
RSR.J. Swanson
R.J. Swanson
VPV. Portnichenko
V. Portnichenko
ASAngela Shysh
Angela Shysh
SPS. Pavlovich
S. Pavlovich
VDV. Dosenko
V. Dosenko

1 December 2017 in Pharmacological Reports
Verified
Journal Article
Closed access
OMOksana Maksymchuk
Oksana Maksymchuk
ASAngela Shysh
Angela Shysh
IRInna Rosohatska
Inna Rosohatska
MCMykola Chashchyn
Mykola Chashchyn

21 October 2010 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
JRJana Radosinska
Jana Radosinska
BBBarbara Bacova
Barbara Bacova
IBIveta Bernatova
Iveta Bernatova
JNJana Navarova
Jana Navarova
AZAnna Zhukovska
Anna Zhukovska
NTNarcisa Tribulova
Narcisa Tribulova

16 March 2022 in Life
Verified
Journal Article
Open access
PDF file
ZSZoya Serebrovska
Zoya Serebrovska
LXLei Xi
Lei Xi
LTLesya V. Tumanovska
Lesya V. Tumanovska
ASAngela Shysh
Angela Shysh
SGSergii V. Goncharov
Sergii V. Goncharov
TSTetiana Serebrovska
Tetiana Serebrovska
Intermittent hypoxia-hyperoxia training (IHHT) is a non-pharmacological therapeutic modality for management of some chronic- and age-related pathologies, such as Alzheimer’s disease (AD). Our previous studies demonstrated significant improvement of cognitive function after IHHT in the patients with mild cognitive impairment (MCI). The present study further investigated the effects of IHHT on pro-inflammatory factors in healthy elderly individuals and patients with early signs of AD. Twenty-nine subjects (13 healthy subjects without signs of cognitive impairment syndrome and 16 patients diagnosed with MCI; age 52 to 76 years) were divided into four groups: Healthy+Sham (n = 7), Healthy+IHHT (n = 6), MCI+Sham (n = 6), and MCI+IHHT (n = 10). IHHT was carried out 5 days per week for 3 weeks (total 15 sessions), and each daily session included 4 cycles of 5-min hypoxia (12% FIO2) and 3-min hyperoxia (33% FIO2). Decline in cognitive function indices was observed initially in both MCI+Sham and MCI+IHHT groups. The sham training did not alter any of the parameters, whereas IHHT resulted in improvement in latency of cognitive evoked potentials, along with elevation in APP110, GDF15 expression, and MMP9 activity in both healthy subjects and those with MCI. Increased MMP2 activity, HMGB1, and P-selectin expression and decreased NETs formation and Aβ expression were also observed in the MCI+IHHT group. There was a negative correlation between MoCA score and the plasma GDF15 expression (R = −0.5799, p < 0.05) before the initiation of IHHT. The enhanced expression of GDF15 was also associated with longer latency of the event-related potentials P330 and N200 (R = 0.6263, p < 0.05 and R = 0.5715, p < 0.05, respectively). In conclusion, IHHT upregulated circulating levels of some inflammatory markers, which may represent potential triggers for cellular adaptive reprogramming, leading to therapeutic effects against cognitive dysfunction and neuropathological changes during progression of AD. Further investigation is needed to clarify if there is a causative relationship between the improved cognitive function and the elevated inflammatory markers following IHHT.